青光眼患者加用1%布林佐胺眼用混悬液后的角膜水肿。 - Suppr

Suppr

超能文献

Corneal edema in glaucoma patients after the addition of brinzolamide 1% ophthalmic suspension.

作者信息

Tanimura Hisatoshi, Minamoto Atsushi, Narai Akito, Hirayama Tomoko, Suzuki Mina, Mishima Hiromu K

出版信息

Jpn J Ophthalmol. 2005 Jul-Aug;49(4):332-3. doi: 10.1007/s10384-004-0197-1.

DOI:10.1007/s10384-004-0197-1

PMID:16075340

Abstract

摘要

相似文献

Corneal edema in glaucoma patients after the addition of brinzolamide 1% ophthalmic suspension.

Jpn J Ophthalmol. 2005 Jul-Aug;49(4):332-3. doi: 10.1007/s10384-004-0197-1.

Brinzolamide 1%/timolol 0.5%: safety and efficacy of a new fixed-combination IOP-lowering product for glaucoma.

Curr Med Res Opin. 2010 Nov;26(11):2575-8. doi: 10.1185/03007995.2010.517718. Epub 2010 Sep 27.

Periocular allergic contact dermatitis caused by brinzolamide.

Contact Dermatitis. 2021 Apr;84(4):274-276. doi: 10.1111/cod.13730. Epub 2020 Nov 3.

Effects of topical administration of 1% brinzolamide on intraocular pressure in clinically normal horses.

Equine Vet J. 2008 Nov;40(7):662-5. doi: 10.2746/042516408X297426.

Brinzolamide induced reversible corneal decompensation.

Br J Ophthalmol. 2005 Mar;89(3):389-90. doi: 10.1136/bjo.2004.049544.

[Therapy of normal tension glaucoma: effect of brinzolamide on ocular haemodynamics].

Klin Monbl Augenheilkd. 2003 May;220(5):330-3. doi: 10.1055/s-2003-39432.

Three-month randomized trial of fixed-combination brinzolamide, 1%, and brimonidine, 0.2%.

JAMA Ophthalmol. 2013 Jun;131(6):724-30. doi: 10.1001/jamaophthalmol.2013.188.

[Impact of prostaglandin-F(2alpha)-analogues and carbonic anhydrase inhibitors on central corneal thickness -- a cross-sectional study on 403 eyes].

Klin Monbl Augenheilkd. 2004 Sep;221(9):753-6. doi: 10.1055/s-2004-81361.

Signs and symptoms of ocular surface status in glaucoma patients switched from timolol 0.5% to brinzolamide 1%/timolol 0.5% fixed combination: a 6-month efficacy and tolerability, multicenter, open-label prospective study.

Expert Opin Pharmacother. 2011 Apr;12(5):685-90. doi: 10.1517/14656566.2011.557361. Epub 2011 Mar 9.

[Successful pressure decrease and improved patient quality of life by Trusopt].

Klin Monbl Augenheilkd. 1996 Apr;208(4):11-2.

引用本文的文献

Stable Gastric Pentadecapeptide BPC 157-Possible Novel Therapy of Glaucoma and Other Ocular Conditions.

Pharmaceuticals (Basel). 2023 Jul 24;16(7):1052. doi: 10.3390/ph16071052.

The Multifarious Effects of Various Glaucoma Pharmacotherapy on Corneal Endothelium: A Narrative Review.

Ophthalmol Ther. 2023 Jun;12(3):1457-1478. doi: 10.1007/s40123-023-00699-9. Epub 2023 Mar 17.

A Narrative Review of Ocular Surface Disease Related to Anti-Glaucomatous Medications.

Ophthalmol Ther. 2022 Oct;11(5):1681-1704. doi: 10.1007/s40123-022-00557-0. Epub 2022 Aug 9.

CD147 required for corneal endothelial lactate transport.

Invest Ophthalmol Vis Sci. 2014 Jun 26;55(7):4673-81. doi: 10.1167/iovs.14-14386.

Effects of common topical antiglaucoma medications on the ocular surface, eyelids and periorbital tissue.

Drugs Aging. 2011 Apr 1;28(4):267-82. doi: 10.2165/11588830-000000000-00000.

Knockdown of NBCe1 in vivo compromises the corneal endothelial pump.

Invest Ophthalmol Vis Sci. 2010 Oct;51(10):5190-7. doi: 10.1167/iovs.10-5257. Epub 2010 May 5.

Role of carbonic anhydrase IV in corneal endothelial HCO3- transport.

Invest Ophthalmol Vis Sci. 2008 Mar;49(3):1048-55. doi: 10.1167/iovs.07-1188.

本文引用的文献

[Effect of various anti-glaucoma eyedrops on human corneal epithelial cells].

Nippon Ganka Gakkai Zasshi. 2004 Feb;108(2):75-83.

Preclinical overview of brinzolamide.

Surv Ophthalmol. 2000 Jan;44 Suppl 2:S119-29. doi: 10.1016/s0039-6257(99)00108-3.

Irreversible corneal decompensation in patients treated with topical dorzolamide.

Am J Ophthalmol. 1999 Apr;127(4):403-6. doi: 10.1016/s0002-9394(98)00438-3.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验